2024 Approvals
What is the name of the drug and what does it do? Yorvipath (pronounced YOR-vih-path), generic name palopegteriparatide, is a medication used to treat adults with hypoparathyroidism, a condition where the parathyroid glands don’t produce enough parathyroid hormone (PTH). This hormone is essential for regulating calcium and phosphate levels
Health and Medical Research News
What Did the Research Discover? Researchers investigated whether high blood pressure (hypertension) and the use of antihypertensive medications affect the risk of developing Alzheimer’s disease (AD) and other types of dementia in older adults. This study combined data from 31,250 participants across 14 countries, with an average starting
Diabetes
What Did the Research Discover? Scientists conducted a study to see if a medication called tirzepatide could help people maintain and further their weight loss after an intensive diet and exercise program. The study included 579 adults who were overweight or obese but did not have diabetes. Before starting the
Health and Medical Research News
What Did the Research Discover? The research demonstrated that a 10-month quality improvement initiative significantly increased the number of Hepatitis C Virus (HCV) RNA-positive patients who initiated curative treatment in a primary care setting. The proportion of patients who started treatment rose from 66.0% to 75.5%, and of
Diabetes
Can medications for type 2 diabetes also protect the brain? A new meta-analysis published in Movement Disorders Clinical Practice combined results from 24 clinical trials—and found a possible link between newer diabetes medications and a lower risk of Parkinson’s disease.
Health and Medical Research News
A 2023 study in the Journal of the American Board of Family Medicine set out to test exactly that—by bringing Hepatitis C treatment into the hands of primary care doctors. With the help of pharmacist support, mentorship, and digital decision tools, primary care teams saw higher cure rates and greate
Diabetes
What Did the Research Discover? This study explored the relationship between chronotype (morning vs. evening preference) and the risk of developing type 2 diabetes in middle-aged nurses. The findings suggest that nurses with an evening chronotype—those who naturally stay up late and wake up later—are more likely to
Health and Medical Research News
Ever wonder what happens before a new medicine reaches your pharmacy shelf? 💊 In this video, we break down the four phases of clinical trials — from the first safety tests in healthy volunteers to large-scale studies that confirm a drug’s effectiveness and safety.
Health and Medical Research News
Before any new medicine can be sold, it must go through several steps of testing called clinical trials. These studies help doctors and scientists learn whether a drug is safe, whether it works, and what side effects it might cause. What Is a Phase 1 Clinical Trial? Phase 1 is
Diabetes
What Did the Research Discover? This study investigated whether lifestyle interventions (LI) for preventing type 2 diabetes are equally effective for all individuals with prediabetes or if different approaches are needed based on individual risk levels. The researchers categorized participants into low-risk (LR) and high-risk (HR) phenotypes based on factors
Health and Medical Research News
Do your natural sleep habits affect your risk of type 2 diabetes? A 2023 study published in Annals of Internal Medicine followed over 63,000 middle-aged nurses to explore whether being a night owl or morning person impacts diabetes risk—even after accounting for diet, weight, and lifestyle.
2025 Approvals
What is it prescribed for? BLUJEPA is prescribed for the treatment of female adults and pediatric patients 12 years of age and older (weighing at least 40 kilograms, or 88 pounds) with uncomplicated urinary tract infections (uUTIs) caused by certain bacteria, including Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus